ClearPoint Neuro Inc.

NASDAQ: CLPT · Real-Time Price · USD
11.66
-0.02 (-0.17%)
At close: Aug 15, 2025, 12:28 PM

ClearPoint Neuro Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
33.59M 32.24M 31.39M 30.43M 28.07M 26.16M 23.95M 22.32M 21.7M 20.95M 20.55M 19.66M 19.09M 17.3M 16.3M 15.73M 14.68M 13.74M
Cost of Revenue
13.3M 12.51M 12.27M 12.06M 11.27M 11.22M 10.34M 9.4M 8.35M 7.47M 7.02M 6.16M 6.21M 5.39M 5.02M 5.46M 4.69M 4.21M
Gross Profit
20.3M 19.73M 19.12M 18.37M 16.8M 14.94M 13.61M 12.92M 13.36M 13.49M 13.53M 13.5M 12.88M 11.91M 11.28M 10.28M 9.99M 9.54M
Operating Income
-22.62M -21.68M -19.75M -18.85M -18.57M -20.96M -22.45M -22.21M -21.11M -18.18M -16.33M -15.85M -15.85M -15.06M -13.37M -11.66M -9.12M -7.19M
Interest Income
586K 912K 872K 737K 628K 383K 386K 379K 311K 230K 116K 32K n/a n/a n/a n/a n/a n/a
Pretax Income
-22.18M -20.78M -18.91M -18.15M -17.98M -20.63M -22.09M -21.86M -20.83M -18.09M -16.43M -16.2M -16.39M -15.83M -14.41M -11.84M -9.35M -7.27M
Net Income
-22.22M -20.79M -18.91M -18.15M -17.98M -20.63M -21.87M -21.55M -20.53M -17.88M -16.54M -16.39M -16.59M -15.93M -14.41M -11.84M -9.35M -7.27M
Selling & General & Admin
29.06M 28.26M 26.48M 25.51M 24.55M 24.59M 24.35M 22.45M 21.76M 20.28M 18.97M 19.34M 18.55M 16.95M 15.61M 13.79M 12.39M 11.31M
Research & Development
13.86M 13.15M 12.39M 11.71M 10.83M 11.31M 11.71M 12.68M 12.71M 11.38M 10.89M 10M 10.18M 10.02M 9.05M 8.14M 6.72M 5.42M
Other Expenses
n/a n/a n/a n/a n/a -2K -13K -13K -38K -44K -22K -25K 62K 70K 34K 37K -36.49K -25.64K
Operating Expenses
42.92M 41.41M 38.87M 37.22M 35.37M 35.9M 36.06M 35.13M 34.46M 31.67M 29.86M 29.35M 28.73M 26.97M 24.66M 21.93M 19.11M 16.73M
Interest Expense
80K n/a n/a n/a n/a n/a n/a n/a n/a 91K 197K 361K 599K 748K 974K 1.01M 977.25K 934.36K
Selling & Marketing Expenses
15.21M 15.02M 14.48M 14.02M 13.31M 12.95M 12.6M 12.44M 11.73M 10.45M 9.36M 8.01M 7.7M 7.1M 6.83M 6.46M 6.13M 5.66M
Cost & Expenses
56.21M 53.91M 51.14M 49.28M 46.64M 47.13M 46.4M 44.53M 42.81M 39.13M 36.88M 35.5M 34.94M 32.36M 29.67M 27.39M 23.8M 20.94M
Income Tax Expense
7K -18K 15K 15K 15K 15K -217K -301K -308K -209K 103K 187K 194K 58K -37K -37K -37K n/a
Shares Outstanding (Basic)
28.26M 27.72M 27.03M 27.59M 27.47M 25.45M 24.63M 24.63M 24.58M 24.58M 24.53M 24.5M 23.99M 23.68M 22.52M 22.11M 21.52M 18.85M
Shares Outstanding (Diluted)
28.26M 27.72M 27.03M 27.59M 27.47M 25.45M 24.63M 24.63M 24.58M 24.58M 24.53M 24.5M 23.99M 23.68M 22.52M 22.52M 21.52M 18.85M
EPS (Basic)
-0.81 -0.76 -0.7 -0.69 -0.71 -0.84 -0.9 -0.89 -0.84 -0.73 -0.68 -0.68 -0.71 -0.7 -0.66 -0.57 -0.49 -0.43
EPS (Diluted)
-0.81 -0.76 -0.7 -0.69 -0.71 -0.84 -0.9 -0.89 -0.84 -0.73 -0.68 -0.68 -0.71 -0.7 -0.66 -0.57 -0.49 -0.43
EBITDA
-21.65M -20.25M -17.84M -16.99M -16.79M -19.23M -20.91M -20.86M -20.01M -17.27M -15.47M -15.04M -14.97M -14.32M -12.74M -10.01M -7.66M -5.72M
EBIT
-22.52M -21.52M -19.75M -18.85M -18.57M -20.96M -22.45M -22.21M -21.11M -18.18M -16.33M -15.85M -15.79M -15.09M -13.44M -10.83M -8.37M -6.33M
Depreciation & Amortization
1.3M 1.76M 1.9M 1.86M 1.78M 1.66M 1.46M 1.19M 933K 829K 777K 803K 817K 763K 692K 818.21K 713.21K 615.21K